Meetings: Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments

TitleMeetings: Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments
ToC Doc Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments
Docket Number2022-10131
Type Notice
Subject Meetings:
Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments
Publication Date2022-05-12
Last Updated Date 2022-05-11 08:15:10 -0400
Last Public Inspection2022-05-11
Filed At2022-05-11T08:45:00.000-04:00
PDF 2022-10131_PI.pdf (79799 bytes)
Download TXT / HTML / JSON
Number of Pages 6
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021